Mutation Burden Independently Predicts Survival in the Pan-Cancer Atlas
JR Smith, FF Parl, WD Dupont - JCO Precision Oncology, 2023 - ascopubs.org
PURPOSE Long-standing clinical predictors of cancer survival have included
histopathologic type, stage, and grade. We hypothesized that the principal categories of …
histopathologic type, stage, and grade. We hypothesized that the principal categories of …
[PDF][PDF] Tumour mutation burden in oestrogen receptor positive breast cancer
CF McGuinness - 2022 - ourarchive.otago.ac.nz
Immune checkpoint blockade (ICB) is a cancer therapy that is based on promoting an
antitumour immune response. Tumour mutation burden (TMB) is an effective biomarker for …
antitumour immune response. Tumour mutation burden (TMB) is an effective biomarker for …